Agilent Technologies Director Mikael Dolsten Files Form 144 to Sell $95.9K in Stock
AGILENT TECHNOLOGIES, INC.
Subscribe to track A
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
Form 144 Notice of Proposed Sale of Securities Company: AGILENT TECHNOLOGIES, INC. (NYSE: A) Insider: Mikael Dolsten (Director) Shares to Sell: 634 Common Shares Total Value: $95,971.75 (~$151.37/share) Approximate Sale Date: 09/04/2026 Broker: Fidelity Brokerage Services LLC Acquisition: Restricted Stock Vesting (03/19/2026)
Comprehensive Analysis
Form 144 Analysis: AGILENT TECHNOLOGIES, INC.
Executive Summary
On September 4, 2026, Mikael Dolsten, a Director at AGILENT TECHNOLOGIES, INC., filed a Form 144 notice indicating an intention to sell 634 shares of Common Stock through Fidelity Brokerage Services LLC. The aggregate market value of the shares to be sold is approximately $95,971.75, implying an estimated price of $151.37 per share.
Transaction Details
- Filer: Mikael Dolsten (Director)
- Issuer: AGILENT TECHNOLOGIES, INC. (CIK:
0001090872) - Security: Common Stock
- Proposed Sale Date: September 4, 2026
- Number of Shares: 634
- Aggregate Market Value: $95,971.75
- Shares Outstanding: 281,928,854
- Acquisition Origin: Shares were originally acquired on March 19, 2026, via restricted stock vesting as part of director equity compensation.
Significance & Market Impact
- Trading Significance: Low
- Volume Impact: The 634 shares represent a negligible fraction (<0.001%) of the company's 281.9 million outstanding shares.
- Context: The proposed sale consists of equity received through standard compensation vesting and is modest in size, indicating standard personal portfolio management rather than a material signal on company fundamentals.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.
